Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 241

1.

Temporal cortex hypermetabolism in Down syndrome prior to the onset of dementia.

Haier RJ, Alkire MT, White NS, Uncapher MR, Head E, Lott IT, Cotman CW.

Neurology. 2003 Dec 23;61(12):1673-9.

PMID:
14694028
2.
3.

Reduced cerebral glucose metabolism in patients at risk for Alzheimer's disease.

Hunt A, Schönknecht P, Henze M, Seidl U, Haberkorn U, Schröder J.

Psychiatry Res. 2007 Jul 15;155(2):147-54. Epub 2007 May 23.

PMID:
17524628
4.

Cerebral metabolic changes accompanying conversion of mild cognitive impairment into Alzheimer's disease: a PET follow-up study.

Drzezga A, Lautenschlager N, Siebner H, Riemenschneider M, Willoch F, Minoshima S, Schwaiger M, Kurz A.

Eur J Nucl Med Mol Imaging. 2003 Aug;30(8):1104-13. Epub 2003 May 23.

PMID:
12764551
5.

Decreased cortical glucose metabolism in converters from CDR 0.5 to Alzheimer's disease in a community: the Osaki-Tajiri Project.

Ishii H, Ishikawa H, Meguro K, Tashiro M, Yamaguchi S.

Int Psychogeriatr. 2009 Feb;21(1):148-56. doi: 10.1017/S1041610208008132. Epub 2008 Dec 1.

PMID:
19040787
6.

The cortical topography of temporal lobe hypometabolism in early Alzheimer's disease.

Jagust WJ, Eberling JL, Richardson BC, Reed BR, Baker MG, Nordahl TE, Budinger TF.

Brain Res. 1993 Dec 3;629(2):189-98.

PMID:
8111623
7.

Detection of an Alzheimer disease pattern of cerebral metabolism in Down syndrome.

Azari NP, Pettigrew KD, Pietrini P, Horwitz B, Schapiro MB.

Dementia. 1994 Mar-Apr;5(2):69-78.

PMID:
8038869
8.

Imaging of amyloid plaques and cerebral glucose metabolism in semantic dementia and Alzheimer's disease.

Drzezga A, Grimmer T, Henriksen G, Stangier I, Perneczky R, Diehl-Schmid J, Mathis CA, Klunk WE, Price J, DeKosky S, Wester HJ, Schwaiger M, Kurz A.

Neuroimage. 2008 Jan 15;39(2):619-33. Epub 2007 Sep 21.

PMID:
17962045
9.

Cerebral glucose metabolism in patients with frontotemporal dementia.

Ishii K, Sakamoto S, Sasaki M, Kitagaki H, Yamaji S, Hashimoto M, Imamura T, Shimomura T, Hirono N, Mori E.

J Nucl Med. 1998 Nov;39(11):1875-8.

10.

Cerebral metabolic differences in Parkinson's and Alzheimer's diseases matched for dementia severity.

Vander Borght T, Minoshima S, Giordani B, Foster NL, Frey KA, Berent S, Albin RL, Koeppe RA, Kuhl DE.

J Nucl Med. 1997 May;38(5):797-802.

11.

Impaired cerebral glucose metabolism in prodromal Alzheimer's disease differs by regional intensity normalization.

Küntzelmann A, Guenther T, Haberkorn U, Essig M, Giesel F, Henze R, Schroeter ML, Schröder J, Schönknecht P.

Neurosci Lett. 2013 Feb 8;534:12-7. doi: 10.1016/j.neulet.2012.11.026. Epub 2012 Nov 23.

PMID:
23182881
12.

Cerebral blood flow and metabolic abnormalities in Alzheimer's disease.

Matsuda H.

Ann Nucl Med. 2001 Apr;15(2):85-92. Review.

PMID:
11448080
13.

[Measurement of regional cerebral metabolism rate of glucose in patients with Alzheimer's disease in different levels of severity].

Xiao SF, Cao QY, Xue HB, Liu YC, Zuo CT, Jiang KD, Zhang MY.

Zhonghua Yi Xue Za Zhi. 2005 Nov 9;85(42):2975-9. Chinese.

PMID:
16324383
14.

Activation in the premotor cortex during mental calculation in patients with Alzheimer's disease: relevance of reduction in posterior cingulate metabolism.

Ouchi Y, Yoshikawa E, Futatsubashi M, Okada H, Torizuka T, Kaneko M.

Neuroimage. 2004 May;22(1):155-63.

PMID:
15110005
15.

18FDG PET in vascular dementia: differentiation from Alzheimer's disease using voxel-based multivariate analysis.

Kerrouche N, Herholz K, Mielke R, Holthoff V, Baron JC.

J Cereb Blood Flow Metab. 2006 Sep;26(9):1213-21. Epub 2006 Mar 8.

16.

Regional glucose metabolic abnormalities are not the result of atrophy in Alzheimer's disease.

Ibáñez V, Pietrini P, Alexander GE, Furey ML, Teichberg D, Rajapakse JC, Rapoport SI, Schapiro MB, Horwitz B.

Neurology. 1998 Jun;50(6):1585-93.

PMID:
9633698
17.

Positron emission tomography metabolic correlates of apathy in Alzheimer disease.

Marshall GA, Monserratt L, Harwood D, Mandelkern M, Cummings JL, Sultzer DL.

Arch Neurol. 2007 Jul;64(7):1015-20.

PMID:
17620493
18.

Individual cerebral metabolic deficits in Alzheimer's disease and amnestic mild cognitive impairment: an FDG PET study.

Del Sole A, Clerici F, Chiti A, Lecchi M, Mariani C, Maggiore L, Mosconi L, Lucignani G.

Eur J Nucl Med Mol Imaging. 2008 Jul;35(7):1357-66. doi: 10.1007/s00259-008-0773-6. Epub 2008 Apr 17.

PMID:
18418593
19.

Differentiation of Alzheimer's disease from dementia with Lewy bodies utilizing positron emission tomography with [18F]fluorodeoxyglucose and neuropsychological testing.

Gilman S, Koeppe RA, Little R, An H, Junck L, Giordani B, Persad C, Heumann M, Wernette K.

Exp Neurol. 2005 Feb;191 Suppl 1:S95-S103.

PMID:
15629765
20.

Functional interactions of the entorhinal cortex: an 18F-FDG PET study on normal aging and Alzheimer's disease.

Mosconi L, Pupi A, De Cristofaro MT, Fayyaz M, Sorbi S, Herholz K.

J Nucl Med. 2004 Mar;45(3):382-92.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk